Optimizing selective estrogen receptor degraders for anticancer drug development.

ABSTRACT:

SUBMITTER: Bhatia N 

PROVIDER: S-EPMC11938951 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature